azitra, inc. is a preclinical stage biotechnology company harnessing the power of the microbiome to treat skin disease. the company was founded in 2014 by scientists from yale university and works with world-leading scientists in dermatology, microbiology, and genetic engineering to advance its programs in atopic dermatitis and targeted orphan indications. for more information visit www.azitrainc.com.